Patent ID: 7927812

Claim:
A method for diagnosing ischemic coronary artery disease caused by a coronary vessel disease in an asymptomatic patient belonging to a risk group selected from the group consisting of smokers, patients suffering from diabetes, obese patients, patients suffering from hyperlipidemia, patients suffering from arterial hypertension, patients having a family history of any of coronary artery disease, myocardial infarction, or stroke, and patients suffering from rheumatoid arthritis, the method comprising the steps of: measuring in vitro an amount of a cardiac troponin in a sample from the patient, measuring in vitro an amount of a natriuretic peptide in the sample, comparing the amount of the cardiac troponin measured with a reference amount of the cardiac troponin and comparing the amount of natriuretic peptide measured with a reference amount of natriuretic peptide, wherein the reference amounts are derived from asymptomatic individuals, and diagnosing the disease where the measured amounts are elevated over the reference amounts, wherein the reference amount of the cardiac troponin is at least 0.003 ng/ml and the reference amount of natriuretic peptide is at least 150 pg/ml.